Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal plasma membrane ergosterol-containing lipid bilayer is a fundamental structural component of fungal cells, where ergosterol serves as the primary sterol, analogous to cholesterol in mammalian cells (Luo et al., 2021, 'Ergosterol: A Review'). It plays a critical role in maintaining membrane fluidity, integrity, and the proper functioning of membrane-associated proteins and transport systems (Wikipedia, 'Ergosterol'). This lipid bilayer is a primary target for polyene antifungal agents, such as amphotericin B and nystatin, which bind specifically to ergosterol (StatPearls, 'Amphotericin B'). The interaction between these drugs and the ergosterol-rich bilayer leads to the formation of aqueous pores or the sequestration of ergosterol into 'sponges,' resulting in the leakage of essential intracellular components like potassium ions and ultimately causing cell death (Gray et al., 2012, 'Amphotericin B causes cell death by sequestering ergosterol'). Because ergosterol is absent in human cell membranes, this bilayer provides a basis for selective toxicity, although high doses can lead to side effects due to structural similarities between ergosterol and human cholesterol (NIH, 'Antifungal Agents').
Direct binding to ergosterol molecules within the fungal plasma membrane, leading to the formation of transmembrane pores or the sequestration of sterols into large aggregates, which causes rapid leakage of intracellular ions (e.g., K+) and small molecules, resulting in fungal cell death.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal plasma membrane ergosterol-containing lipid bilayer.